AIP
INSY

Ameritas Investment Partners’s Insys Therapeutics, Inc. INSY Stock Holding History

Ameritas Investment Partners’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,760
Closed -$8K – 3177
2019
Q1 		$8K Hold
1,760
– – ﹤0.01% 2783
2018
Q4 		$6K Hold
1,760
– – ﹤0.01% 2844
2018
Q3 		$18K Hold
1,760
– – ﹤0.01% 2571
2018
Q2 		$13K Hold
1,760
– – ﹤0.01% 2765
2018
Q1 		$11K Hold
1,760
– – ﹤0.01% 2709
2017
Q4 		$17K Hold
1,760
– – ﹤0.01% 2528
2017
Q3 		$16K Hold
1,760
– – ﹤0.01% 2554
2017
Q2 		$22K Hold
1,760
– – ﹤0.01% 2406
2017
Q1 		$18K Buy
+1,760
New +$18.8K ﹤0.01% 2481

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Ameritas Investment Partners's INSY Position: Q2 2019 in Review

Ameritas Investment Partners sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 1,760 shares — an estimated $8K sold.

Ameritas Investment Partners first reported a position in INSY in Q1 2017 and held it in 9 quarters. The position peaked at $22K in Q2 2017. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Ameritas Investment Partners reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Ameritas Investment Partners sold 1,760 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $8K.
  • Ameritas Investment Partners first reported a position in Insys Therapeutics, Inc. in Q1 2017 and held it in 9 quarters.
  • Ameritas Investment Partners's Insys Therapeutics, Inc. position peaked at $22K in Q2 2017.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Ameritas Investment Partners's 13F filing for Q2 2019, filed 14 Aug 2019.